These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10700949)

  • 1. Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients.
    White SA; Bicknell GR; Jain S; Williams ST; Doughman T; Furness P; Nicholson ML
    Transplant Proc; 2000 Feb; 32(1):19-20. PubMed ID: 10700949
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection.
    Brook NR; White SA; Waller JR; Bicknell GR; Nicholson ML
    Br J Surg; 2003 Aug; 90(8):1009-14. PubMed ID: 12905557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants.
    Bicknell GR; Williams ST; Shaw JA; Pringle JH; Furness PN; Nicholson ML
    Br J Surg; 2000 Nov; 87(11):1569-75. PubMed ID: 11091247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is TGF-beta a profibrotic cytokine in human renal transplants?
    Nicholson ML; Bicknell GR; Williams ST; Furness PN
    Transplant Proc; 1998 Jun; 30(4):952. PubMed ID: 9636384
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy.
    Saunders RN; Bicknell GR; Nicholson ML
    Transplantation; 2003 Mar; 75(6):772-80. PubMed ID: 12660500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fibrosis-associated genes after renal transplantation from cadaveric and non-heart-beating donors.
    Jain S; White SA; Bicknell GR; Williams ST; Furness PN; Nicholson ML
    Transplant Proc; 2000 Feb; 32(1):190. PubMed ID: 10701019
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
    Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
    Khanna A; Plummer M; Bromberek C; Bresnahan B; Hariharan S
    Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron-microscopic peritubular capillary lesion is a specific and useful diagnostic indicator for chronic rejection of renal allografts showing less specific morphologic lesions in the cyclosporine era.
    Morozumi K; Oikawa T; Fukuda M; Sugito K; Takeuchi O; Usami T; Fujinami T; Yokoyama I; Takagi H; Takeda A; Koyama K; Yoshida A; Haba T; Tominaga Y; Uchida K
    Transplant Proc; 1997; 29(1-2):89-92. PubMed ID: 9123167
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection.
    McGrath JS; Shehata M
    Transplant Proc; 2001 May; 33(3):2191-2. PubMed ID: 11377499
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrolimus rescue therapy for renal transplant rejection.
    Jordan ML; Shapiro R; Naraghi R; Smith D; Vivas C; Gritsch HA; Scantlebury V; Randhawa P; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1996 Aug; 28(4):2119-20. PubMed ID: 8769174
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrolimus for rescue therapy in refractory renal allograft rejection.
    Jang HJ; Kim SC; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1765-6. PubMed ID: 11119925
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of chronic rejection using peritubular and glomerular capillary lesions.
    Morozumi K; Oikawa T; Fukuda M; Sugito K; Takeuchi O; Oda A; Fujinami T; Takeda A; Uchida K
    Transplant Proc; 1996 Feb; 28(1):508-11. PubMed ID: 8644331
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
    Turner CD; Bruce DS; Cronin DC; Loss GE; Grewal H; Siegel C; Millis JM; Newell KA; Davis B; Todo T; Thistlethwaite JR; Woodle ES
    Transplant Proc; 1998 Jun; 30(4):1234-5. PubMed ID: 9636501
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR;
    Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract]   [Full Text] [Related]  

  • 16. Five-year experience with tacrolimus rescue for renal allograft rejection.
    Jordan ML; Naraghi RN; Shapiro R; Smith D; Vivas CA; Scantlebury VP; Gritsch HA; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE
    Transplant Proc; 1997; 29(1-2):306. PubMed ID: 9123009
    [No Abstract]   [Full Text] [Related]  

  • 17. Histopathological findings according to Banff-97 classification system comparing tacrolimus versus cyclosporine.
    Rodrigo E; Escallada R; Fernández-Fresnedo G; Ruiz JC; Piñera C; Herráez I; Cotorruelo JG; Zubimendi JA; de Francisco AL; Arias M
    Transplant Proc; 2002 Aug; 34(5):1719-20. PubMed ID: 12176550
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of RS61443 on chronic rejection of rat kidney allografts.
    Azuma H; Binder J; Heemann U; Tullius SG; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):436-7. PubMed ID: 7879052
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months.
    Budde K; Fritsche L; Smettan S; Schönberger B; Loening SA; Mai I; Bauer S; Waiser J; Neumayer HH
    Transplant Proc; 1998 Jun; 30(4):1238-9. PubMed ID: 9636503
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.